Name | Number of supported studies | Average coverage | |
---|---|---|---|
classical monocyte | 7 studies | 22% ± 6% | |
macrophage | 7 studies | 23% ± 8% | |
non-classical monocyte | 6 studies | 21% ± 3% | |
conventional dendritic cell | 5 studies | 27% ± 13% | |
dendritic cell | 4 studies | 28% ± 9% |
Insufficient scRNA-seq data for expression of TNFAIP8L2 at tissue level.
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
lung | 99% | 358.31 | 570 / 578 | 92% | 13.25 | 1065 / 1155 |
breast | 93% | 124.66 | 425 / 459 | 96% | 13.38 | 1077 / 1118 |
bladder | 100% | 132.43 | 21 / 21 | 71% | 8.86 | 356 / 504 |
intestine | 90% | 177.38 | 873 / 966 | 75% | 6.74 | 396 / 527 |
brain | 65% | 81.52 | 1722 / 2642 | 97% | 20.18 | 685 / 705 |
stomach | 75% | 81.60 | 269 / 359 | 81% | 7.79 | 231 / 286 |
prostate | 87% | 113.23 | 212 / 245 | 68% | 4.49 | 339 / 502 |
uterus | 69% | 63.22 | 117 / 170 | 84% | 10.28 | 384 / 459 |
adrenal gland | 93% | 182.85 | 239 / 258 | 56% | 4.34 | 128 / 230 |
thymus | 64% | 67.50 | 415 / 653 | 83% | 17.05 | 505 / 605 |
kidney | 54% | 71.13 | 48 / 89 | 90% | 14.88 | 808 / 901 |
esophagus | 78% | 79.86 | 1127 / 1445 | 63% | 4.50 | 115 / 183 |
skin | 53% | 39.82 | 957 / 1809 | 82% | 13.64 | 388 / 472 |
pancreas | 45% | 36.02 | 149 / 328 | 89% | 12.19 | 158 / 178 |
ovary | 49% | 41.58 | 89 / 180 | 80% | 8.18 | 346 / 430 |
liver | 47% | 60.58 | 107 / 226 | 72% | 6.64 | 293 / 406 |
lymph node | 0% | 0 | 0 / 0 | 100% | 113.97 | 29 / 29 |
peripheral blood | 100% | 2822.83 | 929 / 929 | 0% | 0 | 0 / 0 |
spleen | 100% | 1943.28 | 241 / 241 | 0% | 0 | 0 / 0 |
adipose | 96% | 204.26 | 1161 / 1204 | 0% | 0 | 0 / 0 |
tonsil | 0% | 0 | 0 / 0 | 91% | 16.00 | 41 / 45 |
blood vessel | 76% | 118.21 | 1014 / 1335 | 0% | 0 | 0 / 0 |
heart | 54% | 49.46 | 465 / 861 | 0% | 0 | 0 / 0 |
eye | 0% | 0 | 0 / 0 | 40% | 3.33 | 32 / 80 |
muscle | 9% | 4.98 | 75 / 803 | 0% | 0 | 0 / 0 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
ureter | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 1 |
GO_0050868 | Biological process | negative regulation of T cell activation |
GO_0050728 | Biological process | negative regulation of inflammatory response |
GO_0042981 | Biological process | regulation of apoptotic process |
GO_0042110 | Biological process | T cell activation |
GO_0045087 | Biological process | innate immune response |
GO_0005764 | Cellular component | lysosome |
GO_0005737 | Cellular component | cytoplasm |
GO_0005634 | Cellular component | nucleus |
GO_0005515 | Molecular function | protein binding |
Gene name | TNFAIP8L2 |
Protein name | Tumor necrosis factor alpha-induced protein 8-like protein 2 (TIPE2) (TNF alpha-induced protein 8-like protein 2) (TNFAIP8-like protein 2) (Inflammation factor protein 20) |
Synonyms | |
Description | FUNCTION: Acts as a negative regulator of innate and adaptive immunity by maintaining immune homeostasis . Plays a regulatory role in the Toll-like signaling pathway by determining the strength of LPS-induced signaling and gene expression . Inhibits TCR-mediated T-cell activation and negatively regulate T-cell function to prevent hyperresponsiveness (By similarity). Inhibits also autolysosome formation via negatively modulating MTOR activation by interacting with RAC1 and promoting the disassociation of the RAC1-MTOR complex . Plays an essential role in NK-cell biology by acting as a checkpoint and displaying an expression pattern correlating with NK-cell maturation process and by negatively regulating NK-cell maturation and antitumor immunity (By similarity). Mechanistically, suppresses IL-15-triggered mTOR activity in NK-cells (By similarity). . |
Accessions | Q6P589 ENST00000368910.4 |